CERS Q2 2019 Earnings — Cerus Corporation Revenue & Financial Results | Market Cap Arena

CERSCerus Corporation

$335M

Q2 2019 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$18M+18.1% YoY

Gross Profit

$10M55.5% margin

Operating Income

-$17M-92.2% margin

Net Income

-$18M-96.4% margin

EPS (Diluted)

$-0.13

QoQ Revenue Growth

+4.0%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$16M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$175M

Total Liabilities

$109M

Stockholders' Equity

$66M

Cash & Equivalents

$24M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$18M	$15M	+18.1%
Gross Profit	$10M	$8M	+31.1%
Operating Income	-$17M	-$13M	-33.6%
Net Income	-$18M	-$13M	-32.2%

Revenue Segments

Product

$18M81%

Government Contract

$4M19%

Geographic Segments

Europe Middle East And Africa

$13M70%

North America

$5M28%

Other

$303,0002%